September 6, 2015
Tel Aviv, Israel
BioExecutive Forum
Whether in the medical device or biopharm space, strong patents are a key component of the valuation of most life sciences companies. In this fast-paced seminar, Finnegan partner Gerson Panitch will explore patents from the perspective of investors, partners, and competitors, and will pinpoint one critical common thread that catches their attention and separates strong from weak patents. In the process, we will identify specific steps life sciences companies can take to maximize the value they receive from their patents. For more information or to register, please see the BioExecutive Forum's website.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.